SubjectVerb relationObjectSentenceSentimentTitleUrlDate
Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Incs infectionfighting treatment Neulasta at 33 percent discount Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Incs infectionfighting treatment Neulasta at a 33 percent discount NegativeCoherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Incs infectionfighting treatment Neulasta at a 33 percent discount http://www.reuters.com/news/health/article/us-coherus-biosimilar/coherus-prices-biosimilar-to-amgens-neulasta-at-33-percent-discount-idUSKCN1ND36Q2018-11-09